{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:00:54Z","timestamp":1789988454622,"version":"4.0.1"},"reference-count":124,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gen Psychiatry"],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.1001\/archgenpsychiatry.2011.16","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T07:19:38Z","timestamp":1299568778000},"page":"732","source":"Crossref","is-referenced-by-count":26,"title":["Brain Regional \u03b1-[<sup>11<\/sup>C]Methyl-<scp>L<\/scp>-Tryptophan Trapping in Medication-Free Patients With Obsessive-Compulsive Disorder"],"prefix":"10.1001","volume":"68","author":[{"given":"Alexandre","family":"Berney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Leyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Sookman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Diksic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Pinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christo","family":"Todorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Okazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Edward","family":"Nordahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawki","family":"Benkelfat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ref-yoa15007-2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pneurobio.2004.02.004","article-title":"Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology.","volume":"72","author":"Aouizerate","year":"2004","journal-title":"Prog Neurobiol"},{"issue":"3","key":"ref-yoa15007-3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"issue":"20","key":"ref-yoa15007-4","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa0708514","article-title":"Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.","volume":"359","author":"Mallet","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"ref-yoa15007-5","first-page":"405","article-title":"Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies.","volume":"33","author":"Rotge","year":"2008","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"ref-yoa15007-6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/10673220216215","article-title":"Pharmacological management of obsessive-compulsive disorder: a review for clinicians.","volume":"10","author":"McDonough","year":"2002","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"ref-yoa15007-7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-0327(87)90023-1","article-title":"Drug treatment of obsessive-compulsive disorder.","volume":"13","author":"Zohar","year":"1987","journal-title":"J Affect Disord"},{"issue":"3","key":"ref-yoa15007-8","first-page":"279","article-title":"Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.","volume":"26","author":"Chouinard","year":"1990","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"ref-yoa15007-9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/archpsyc.1989.01810010025004","article-title":"Clomipramine in obsessive-compulsive disorder: further evidence for a serotonergic mechanism of action.","volume":"46","author":"Benkelfat","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"ref-yoa15007-10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s002130050787","article-title":"Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients.","volume":"140","author":"Greenberg","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"ref-yoa15007-11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/archpsyc.1987.01800230026006","article-title":"Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls.","volume":"44","author":"Zohar","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"ref-yoa15007-12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/archpsyc.1992.01820010021003","article-title":"Serotonergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.","volume":"49","author":"Hollander","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"ref-yoa15007-13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0006-3223(91)90264-M","article-title":"Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.","volume":"29","author":"Pigott","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"2","key":"ref-yoa15007-14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0306-4530(00)00048-2","article-title":"Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder.","volume":"26","author":"Khanna","year":"2001","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"ref-yoa15007-15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0924-977X(01)00082-7","article-title":"Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.","volume":"11","author":"Koran","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"ref-yoa15007-16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000079970","article-title":"Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.","volume":"50","author":"Gross-Isseroff","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"3","key":"ref-yoa15007-17","first-page":"231","article-title":"Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.","volume":"1","author":"Aouizerate","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"ref-yoa15007-18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0006-3223(94)00235-U","article-title":"m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.","volume":"38","author":"Goodman","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"5","key":"ref-yoa15007-19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0006-3223(97)00458-7","article-title":"Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls.","volume":"44","author":"Ho Pian","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"1","key":"ref-yoa15007-20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s002130000529","article-title":"Zolmitriptan (a 5-HT1B\/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder.","volume":"152","author":"Boshuisen","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"ref-yoa15007-21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-1781(92)90081-D","article-title":"Effects of fenfluramine on plasma HVA in OCD.","volume":"42","author":"Hollander","year":"1992","journal-title":"Psychiatry Res"},{"issue":"2","key":"ref-yoa15007-22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/archpsyc.1988.01800260095012","article-title":"Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.","volume":"45","author":"Charney","year":"1988","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"ref-yoa15007-23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0006-3223(95)00393-2","article-title":"Tryptophan depletion in obsessive-compulsive patients.","volume":"40","author":"Smeraldi","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"9","key":"ref-yoa15007-24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.biopsych.2005.08.023","article-title":"Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients.","volume":"59","author":"Berney","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"11","key":"ref-yoa15007-25","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/0006-3223(85)90176-3","article-title":"Obsessive-compulsive disorder and serotonin: is there a connection?","volume":"20","author":"Insel","year":"1985","journal-title":"Biol Psychiatry"},{"issue":"1","key":"ref-yoa15007-26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.1992.01820010029004","article-title":"Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.","volume":"49","author":"Swedo","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"ref-yoa15007-27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archpsyc.1992.01820010009002","article-title":"Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder.","volume":"49","author":"Altemus","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"ref-yoa15007-28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.npp.1380241","article-title":"Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls.","volume":"12","author":"Leckman","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"ref-yoa15007-29","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0006-3223(03)00183-5","article-title":"Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.","volume":"54","author":"Pogarell","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"4","key":"ref-yoa15007-30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00406-004-0489-y","article-title":"Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).","volume":"254","author":"Stengler-Wenzke","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"ref-yoa15007-31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pscychresns.2005.07.002","article-title":"Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.","volume":"140","author":"Hesse","year":"2005","journal-title":"Psychiatry Res"},{"issue":"12","key":"ref-yoa15007-32","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00702-007-0785-6","article-title":"Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity: a [11C]DASB PET study.","volume":"114","author":"Reimold","year":"2007","journal-title":"J Neural Transm"},{"issue":"8","key":"ref-yoa15007-33","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/sj.npp.1301290","article-title":"[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.","volume":"32","author":"Zitterl","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"ref-yoa15007-34","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/S0006-3223(03)00544-4","article-title":"Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.","volume":"54","author":"Simpson","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"12","key":"ref-yoa15007-35","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1176\/appi.ajp.161.12.2201","article-title":"Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]beta-CIT SPECT.","volume":"161","author":"van der Wee","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"6","key":"ref-yoa15007-36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/ajmg.b.30699","article-title":"Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.","volume":"147B","author":"Bloch","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"ref-yoa15007-37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.pnpbp.2005.11.005","article-title":"Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.","volume":"30","author":"El Mansari","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"ref-yoa15007-38","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.biopsych.2007.08.016","article-title":"Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis.","volume":"63","author":"Munaf\u00f2","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"7","key":"ref-yoa15007-39","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/sj.npp.1301283","article-title":"Amygdala-prefrontal disconnection in borderline personality disorder.","volume":"32","author":"New","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"ref-yoa15007-40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.euroneuro.2005.09.006","article-title":"alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters.","volume":"16","author":"Leyton","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"ref-yoa15007-41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1046\/j.1471-4159.2001.00536.x","article-title":"Study of the brain serotonergic system with labeled alpha-methyl-L-tryptophan.","volume":"78","author":"Diksic","year":"2001","journal-title":"J Neurochem"},{"issue":"1","key":"ref-yoa15007-42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004647-200001000-00002","article-title":"Alpha[C-11]methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism.","volume":"20","author":"Chugani","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"ref-yoa15007-43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1990.1","article-title":"A new method to measure brain serotonin synthesis in vivo: I, theory and basic data for a biological model.","volume":"10","author":"Diksic","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"ref-yoa15007-44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jnc.1991.56.issue-1","article-title":"Serotonin synthesis rate measured in living dog brain by positron emission tomography.","volume":"56","author":"Diksic","year":"1991","journal-title":"J Neurochem"},{"issue":"10","key":"ref-yoa15007-45","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1073\/pnas.94.10.5308","article-title":"Differences between males and females in rates of serotonin synthesis in human brain.","volume":"94","author":"Nishizawa","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref-yoa15007-46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys.","volume":"42","author":"Chugani","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"ref-yoa15007-47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/(ISSN)1098-2396","article-title":"Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan.","volume":"28","author":"Chugani","year":"1998","journal-title":"Synapse"},{"issue":"4","key":"ref-yoa15007-48","first-page":"359","article-title":"Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and alpha-[11C]methyl-L-tryptophan.","volume":"25","author":"Okazawa","year":"2000","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"ref-yoa15007-49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1176\/appi.ajp.158.5.775","article-title":"Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder.","volume":"158","author":"Leyton","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"7","key":"ref-yoa15007-50","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1212\/WNL.53.7.1473","article-title":"Increased brain serotonin synthesis in migraine.","volume":"53","author":"Chugani","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"ref-yoa15007-51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children.","volume":"45","author":"Chugani","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"ref-yoa15007-52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/088307380201700403","article-title":"Alpha[11C] methyl-L-typtophan positron emission tomography in patients with alternating hemiplegia of childhood.","volume":"17","author":"Pfund","year":"2002","journal-title":"J Child Neurol"},{"issue":"6","key":"ref-yoa15007-53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archpsyc.61.6.556","article-title":"Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression.","volume":"61","author":"Rosa-Neto","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"ref-yoa15007-54","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1176\/ajp.145.12.1560","article-title":"Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.","volume":"145","author":"Baxter","year":"1988","journal-title":"Am J Psychiatry"},{"issue":"1","key":"ref-yoa15007-55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0893-133X(89)90003-1","article-title":"Cerebral glucose metabolic rates in obsessive compulsive disorder.","volume":"2","author":"Nordahl","year":"1989","journal-title":"Neuropsychopharmacology"},{"issue":"pt 5","key":"ref-yoa15007-56","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/114.5.2191","article-title":"Obsessional slowness: functional studies with positron emission tomography.","volume":"114","author":"Sawle","year":"1991","journal-title":"Brain"},{"issue":"2","key":"ref-yoa15007-57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1192\/bjp.166.2.244","article-title":"[18F]FDG PET study in obsessive-compulsive disorder. A clinical\/metabolic correlation study after treatment.","volume":"166","author":"Perani","year":"1995","journal-title":"Br J Psychiatry"},{"issue":"3","key":"ref-yoa15007-58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0006-3223(01)01123-4","article-title":"Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.","volume":"50","author":"Saxena","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"9","key":"ref-yoa15007-59","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archpsyc.1990.01810210048007","article-title":"Local cerebral glucose metabolic rates in obsessive-compulsive disorder: patients treated with clomipramine.","volume":"47","author":"Benkelfat","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"ref-yoa15007-60","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0193-953X(18)30215-6","article-title":"Neuroimaging studies of obsessive compulsive disorder.","volume":"15","author":"Baxter","year":"1992","journal-title":"Psychiatr Clin North Am"},{"issue":"9","key":"ref-yoa15007-61","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1001\/archpsyc.1992.01820090018003","article-title":"Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy.","volume":"49","author":"Swedo","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"ref-yoa15007-62","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/archpsyc.59.3.250","article-title":"Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.","volume":"59","author":"Saxena","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"ref-yoa15007-63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/archpsyc.1996.01830020023004","article-title":"Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.","volume":"53","author":"Schwartz","year":"1996","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"ref-yoa15007-65","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale: I, development, use, and reliability.","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"ref-yoa15007-66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression.","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"ref-yoa15007-67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0969-8051(94)00116-2","article-title":"Asymmetric radiosynthesis of alpha-[11C]methyl-L-tryptophan for PET studies.","volume":"22","author":"Mzengeza","year":"1995","journal-title":"Nucl Med Biol"},{"issue":"10","key":"ref-yoa15007-68","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/00004647-199810000-00009","article-title":"Validation of a less-invasive method for measurement of serotonin synthesis rate with alpha-[11C]methyl-tryptophan.","volume":"18","author":"Nishizawa","year":"1998","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"ref-yoa15007-69","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1046\/j.1471-4159.1999.0722593.x","article-title":"Biochemical and autoradiographic measurements of brain serotonin synthesis rate in the freely moving rat: a reexamination of the alpha-methyl-L-tryptophan method.","volume":"72","author":"Gharib","year":"1999","journal-title":"J Neurochem"},{"issue":"1","key":"ref-yoa15007-70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.","volume":"3","author":"Patlak","year":"1983","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"ref-yoa15007-71","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space.","volume":"18","author":"Collins","year":"1994","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"ref-yoa15007-72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data.","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"issue":"1","key":"ref-yoa15007-76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000118043","article-title":"Evidence for a biological hypothesis of obsessive-compulsive disorder.","volume":"11","author":"Lieberman","year":"1984","journal-title":"Neuropsychobiology"},{"issue":"4","key":"ref-yoa15007-77","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.neuropsychologia.2006.07.016","article-title":"A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania.","volume":"45","author":"Chamberlain","year":"2007","journal-title":"Neuropsychologia"},{"issue":"2","key":"ref-yoa15007-78","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(ISSN)1098-2396","article-title":"Serotonergic regulation of the GABAergic transmission in the rat basal ganglia.","volume":"50","author":"Di Cara","year":"2003","journal-title":"Synapse"},{"issue":"1-3","key":"ref-yoa15007-79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejphar.2006.10.042","article-title":"Striatal serotonin depletion facilitates rat egocentric learning via dopamine modulation.","volume":"556","author":"Anguiano-Rodr\u00edguez","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"ref-yoa15007-80","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archpsyc.1992.01820090067011","article-title":"Toward a neuroanatomy of obsessive-compulsive disorder.","volume":"49","author":"Insel","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"ref-yoa15007-81","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"issue":"5","key":"ref-yoa15007-82","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s002109900181","article-title":"In vivo electrophysiological examination of 5-HT2 responses in 5-HT2C receptor mutant mice.","volume":"361","author":"Rueter","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"ref-yoa15007-83","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0301-0082(98)00019-7","article-title":"Morphological features of the entorhinal-hippocampal connection.","volume":"55","author":"Turner","year":"1998","journal-title":"Prog Neurobiol"},{"issue":"5409","key":"ref-yoa15007-84","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1126\/science.283.5409.1908","article-title":"Structural maturation of neural pathways in children and adolescents: in vivo study.","volume":"283","author":"Paus","year":"1999","journal-title":"Science"},{"issue":"1-2","key":"ref-yoa15007-85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0166-4328(02)00402-3","article-title":"Mnemonic functions of dorsal striatum and hippocampus in aversive conditioning.","volume":"142","author":"White","year":"2003","journal-title":"Behav Brain Res"},{"issue":"2","key":"ref-yoa15007-86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/nlme.1997.3815","article-title":"Amygdala modulation of multiple memory systems: hippocampus and caudate-putamen.","volume":"69","author":"Packard","year":"1998","journal-title":"Neurobiol Learn Mem"},{"issue":"6","key":"ref-yoa15007-87","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0959-4388(01)00280-X","article-title":"Affective modulation of multiple memory systems.","volume":"11","author":"Packard","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"ref-yoa15007-88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nyas.1986.487.issue-1","article-title":"Conceptualizing a serotonin trait: a behavioral dimension of constraint.","volume":"487","author":"Depue","year":"1986","journal-title":"Ann N Y Acad Sci"},{"issue":"4-5","key":"ref-yoa15007-90","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0010-9452(08)70882-7","article-title":"Hebb, pandemonium and catastrophic hypermnesia: the hippocampus as a suppressor of inappropriate associations.","volume":"39","author":"McNaughton","year":"2003","journal-title":"Cortex"},{"issue":"7","key":"ref-yoa15007-91","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0005-7967(00)00079-6","article-title":"Memory bias, confidence and responsibility in compulsive checking.","volume":"39","author":"Radomsky","year":"2001","journal-title":"Behav Res Ther"},{"issue":"2","key":"ref-yoa15007-92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jbtep.2004.04.007","article-title":"Obsessive-compulsive disorder and the paradoxical effects of perseverative behaviour on experienced uncertainty.","volume":"35","author":"van den Hout","year":"2004","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"5","key":"ref-yoa15007-93","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.tins.2007.03.003","article-title":"Regulation of firing of dopaminergic neurons and control of goal-directed behaviors.","volume":"30","author":"Grace","year":"2007","journal-title":"Trends Neurosci"},{"issue":"6","key":"ref-yoa15007-94","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/cercor\/bhm172","article-title":"Dopamine modulation of hippocampal-prefrontal cortical interaction drives memory-guided behavior.","volume":"18","author":"Goto","year":"2008","journal-title":"Cereb Cortex"},{"issue":"2","key":"ref-yoa15007-96","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00004647-200002000-00004","article-title":"The suitability of [11C]-alpha-methyl-L-tryptophan as a tracer for serotonin synthesis: studies with dual administration of [11C] and [14C] labeled tracer.","volume":"20","author":"Shoaf","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"ref-yoa15007-97","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1023\/A:1026654116999","article-title":"Brain net unidirectional uptake of alpha-[14c]methyl-L-tryptophan (alpha-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and alpha-MTrp.","volume":"25","author":"Diksic","year":"2000","journal-title":"Neurochem Res"},{"issue":"8","key":"ref-yoa15007-98","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuint.2005.07.006","article-title":"Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using alpha-[(11)C]methyl-L-tryptophan and positron emission tomography.","volume":"47","author":"Nishikawa","year":"2005","journal-title":"Neurochem Int"},{"issue":"7","key":"ref-yoa15007-99","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0197-0186(01)00132-2","article-title":"The inhibition of tryptophan hydroxylase, not protein synthesis, reduces the brain trapping of alpha-methyl-L-tryptophan: an autoradiographic study.","volume":"40","author":"Tohyama","year":"2002","journal-title":"Neurochem Int"},{"issue":"3","key":"ref-yoa15007-100","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.brainresbull.2005.07.009","article-title":"The tryptophan hydroxylase activation inhibitor, AGN-2979, decreases regional 5-HT synthesis in the rat brain measured with alpha-[14C]methyl-L-tryptophan: an autoradiographic study.","volume":"67","author":"Hasegawa","year":"2005","journal-title":"Brain Res Bull"},{"issue":"6","key":"ref-yoa15007-101","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/00004647-199706000-00007","article-title":"Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo.","volume":"17","author":"Muzik","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref-yoa15007-102","first-page":"165","article-title":"PET: mapping of serotonin synthesis.","volume":"83","author":"Chugani","year":"2000","journal-title":"Adv Neurol"},{"issue":"4","key":"ref-yoa15007-103","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1017\/S1461145705005420","article-title":"Brain regional alpha-[11C]methyl-L-tryptophan trapping correlates with post-mortem tissue serotonin content and [11C]5-hydroxytryptophan accumulation.","volume":"8","author":"Leyton","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"ref-yoa15007-104","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/sj.jcbfm.9600381","article-title":"5-Hydroxy-L-[beta-11C]tryptophan versus alpha-[11C]methyl-L-tryptophan for positron emission tomography imaging of serotonin synthesis capacity in the rhesus monkey brain.","volume":"27","author":"Lundquist","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"ref-yoa15007-105","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0893-133X(02)00361-5","article-title":"Predictors of mood response to acute tryptophan depletion: a reanalysis.","volume":"27","author":"Booij","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"ref-yoa15007-106","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/archpsyc.1990.01810170011002","article-title":"Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.","volume":"47","author":"Delgado","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"ref-yoa15007-107","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archpsyc.1989.01810030049007","article-title":"Reduction of prefrontal cortex glucose metabolism common to three types of depression.","volume":"46","author":"Baxter","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"ref-yoa15007-108","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0022-3956(97)00016-2","article-title":"The functional neuroanatomy of mood disorders.","volume":"31","author":"Soares","year":"1997","journal-title":"J Psychiatr Res"},{"issue":"2","key":"ref-yoa15007-109","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1176\/appi.ajp.162.2.228","article-title":"A multidimensional model of obsessive-compulsive disorder.","volume":"162","author":"Mataix-Cols","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"12","key":"ref-yoa15007-110","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1176\/appi.ajp.2008.08020320","article-title":"Meta-analysis of the symptom structure of obsessive-compulsive disorder.","volume":"165","author":"Bloch","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2","key":"ref-yoa15007-111","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","article-title":"Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders.","volume":"11","author":"Drevets","year":"2001","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"ref-yoa15007-112","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S1461145705005055","article-title":"Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.","volume":"8","author":"Adams","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"pt 6","key":"ref-yoa15007-113","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/brain\/116.6.1425","article-title":"A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.","volume":"116","author":"Heyes","year":"1993","journal-title":"Brain"},{"issue":"6","key":"ref-yoa15007-114","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/01.WNL.0000049468.05050.F2","article-title":"Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy.","volume":"60","author":"Juh\u00e1sz","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"ref-yoa15007-115","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.jcbfm.9600199","article-title":"In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.","volume":"26","author":"Juh\u00e1sz","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"ref-yoa15007-116","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/sj.mp.4001542","article-title":"PANDAS: current status and directions for research.","volume":"9","author":"Snider","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"3","key":"ref-yoa15007-117","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/0883073809339394","article-title":"Multimodality neuroimaging in Tourette syndrome: alpha-[11C] methyl-L-tryptophan positron emission tomography and diffusion tensor imaging studies.","volume":"25","author":"Saporta","year":"2010","journal-title":"J Child Neurol"},{"key":"ref-yoa15007-118","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1192\/bjp.179.4.330","article-title":"Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images.","volume":"179","author":"Kim","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"7","key":"ref-yoa15007-119","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archpsyc.61.7.720","article-title":"Mapping structural brain alterations in obsessive-compulsive disorder.","volume":"61","author":"Pujol","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"ref-yoa15007-120","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/archpsyc.1995.03950170067009","article-title":"Reduced caudate nucleus volume in obsessive-compulsive disorder.","volume":"52","author":"Robinson","year":"1995","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"ref-yoa15007-121","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archpsyc.1996.01830070021006","article-title":"Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging.","volume":"53","author":"Aylward","year":"1996","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"ref-yoa15007-122","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/npp.2009.175","article-title":"Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis.","volume":"35","author":"Rotge","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"ref-yoa15007-123","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biopsych.2008.06.019","article-title":"Meta-analysis of brain volume changes in obsessive-compulsive disorder.","volume":"65","author":"Rotge","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"7","key":"ref-yoa15007-124","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archgenpsychiatry.2010.70","article-title":"Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders.","volume":"67","author":"Radua","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref-yoa15007-1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"key":"ref-yoa15007-64","volume-title":"Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID I\/P, Version 2.0)","author":"First","year":"1995"},{"key":"ref-yoa15007-73","first-page":"439","article-title":"Automatic quantification of MS lesions in 3D MRI brain data sets: validation of INSECT.","volume-title":"Medical Image Computing and Computer-Assisted Intervention: MICCAI'98: First International Conference, Cambridge, MA, USA, October 11-13, 1998, Proceedings (Lecture Notes in Computer Science)","author":"Zijdenbos","year":"1998"},{"key":"ref-yoa15007-74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/3-540-48714-X_16","article-title":"ANIMAL+INSECT: improved cortical structure segmentation.","volume-title":"Information Processing in Medical Imaging: 16th International Conference, IPMI'99, Visegrad, Hungary, June 28-July 2, 1999, Proceedings (Lecture Notes in Computer Science)","author":"Collins","year":"1999"},{"key":"ref-yoa15007-75","volume-title":"Program for Display and Segmentation of Surfaces and Volumes","author":"MacDonnald","year":"1996"},{"key":"ref-yoa15007-89","volume-title":"The Neuropsychology of Anxiety: An Inquiry Into the Functions of the Septo-Hippocampal System (Oxford Psychology Series)","author":"Gray","year":"2000"},{"key":"ref-yoa15007-95","volume-title":"Obsessive-Compulsive Related Disorders","author":"Hollander","year":"1993"}],"container-title":["Archives of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/1107209\/yoa15007_732_741_1621375535.75809.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T22:31:00Z","timestamp":1621377060000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/1107209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":124,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7,4]]}},"URL":"https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.16","relation":{},"ISSN":["0003-990X"],"issn-type":[{"value":"0003-990X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}